Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yunnan Hongyao (云南红药) is a traditional Chinese medicine (TCM) formula produced by Yunnan Plant Pharmaceutical Industry. It is a multi-herb botanical product available in capsule form, composed of a blend of ingredients including *Ampelopsis delavayana*, *Dolichos tenuicaulis*, *Psammosilene tunicoides*, *Aconitum vilmorinianum*, *Dactylicapnos*, *Scutellaria amoena*, *Acorus tatarinowii*, *Paris polyphylla*, and *Streblus indicus*. Traditionally, it is used for its hemostatic, analgesic, and anti-inflammatory properties. Its primary indications include the treatment of various types of bleeding (gastrointestinal, uterine, hemorrhoidal, and hemoptysis), gastric and duodenal ulcers, soft tissue injuries, and rheumatic arthritis. The formula is traditionally characterized as promoting blood circulation, removing blood stasis, and expelling wind and dampness.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yunnan Hongyao.